Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia

Leukemia & Lymphoma
Mohamed MabedSolafa El-Sharawy

Abstract

B-cell chronic lymphatic leukemia (B-CLL) has emerged as a prototype of malignancies characterized by a defective apoptosis that leads to a progressive accumulation of monoclonal B cells in the bone marrow, lymphoid tissues and peripheral blood. Chlorambucil, an aromatic derivative of nitrogen mustards, is the most common treatment for chronic lymphatic leukemia (CLL). The response rate with its use is 40 to 60%, with 3 to 10% only of patients achieving a complete response (CR). To improve response rates, chlorambucil has been combined with steroids or other agents. Theophylline, a methylxanthine commonly used as a treatment for asthma, has been shown to induce apoptosis in CLL cells both in vitro and in vivo. Chlorambucil induces apoptosis in CLL cells as well and synergy has been shown between the two drugs without affecting the normal B lymphocytes. The aim of this work was to evaluate the potential utility of this combination as a therapeutic modality for B-CLL. A total of 210 B-CLL patients were recruited and randomized to receive either chlorambucil in an oral dose of 0.1 mg/kg/day indefinitely (109 patients) or chlorambucil 0.1 mg/kg/day plus theophylline 200 mg bid, orally (101 patients). The main endpoints were overall...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P ShawJ Costa
Apr 15, 1989·Annals of Internal Medicine·B D ChesonS J Kempin
Aug 1, 1995·British Journal of Haematology·F MentzJ L Binet
Apr 1, 1993·Current Opinion in Cell Biology·E J ChoiD R Storm
Oct 1, 1996·Leukemia & Lymphoma·A BegleiterJ B Johnston
Jul 1, 1997·Current Opinion in Hematology·T J Kipps
Dec 15, 2000·The New England Journal of Medicine·K R RaiC A Schiffer
Oct 6, 2001·Blood·M LeporrierUNKNOWN French Cooperative Group on Chronic Lymphocytic Leukemia
Jun 19, 2002·Biochimica Et Biophysica Acta·Hsinyu LeeEdward J Goetzl
Feb 8, 2003·British Journal of Biomedical Science·Andrew P Jewell
Jan 1, 1961·British Journal of Haematology·D A GALTONJ V DACIE

❮ Previous
Next ❯

Citations

Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lingzhi ZhangPaul A Insel
May 5, 2010·Archives of Environmental & Occupational Health·Ugur Gonlugur, Tanseli Efeoglu Gonlugur

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis